00:00Donald Trump's push to lower US drug prices could lead to European patients waiting longer
00:04for new medicines, according to a new modeling study published in The Lancet.
00:09Trump has pushed for US prices to match the lowest levels offered in other developed countries
00:13under so-called most favored nation pricing.
00:17Researchers examined 195 patented medicines, accounting for $87.9 billion in annual US
00:23spending.
00:24For three in four, they found that losses from lowering US prices would exceed their
00:29total annual sales in the countries where those prices were set.
00:33Researchers say drug makers could respond by delaying launches in lower-priced countries,
00:37including in Europe, to avoid having to match those prices in the United States.
00:42Drug launches in EU markets have already fallen by around 35% over a 10-month period, although
00:48it remains unclear whether US policy is directly responsible.
00:52The study estimates the policy could save billions of dollars in US drug spending.
00:56But the confidential deal struck between 17 companies and the administration could reduce
01:01potential savings by 71%.
01:04The European Commission is assessing whether the policy is already affecting access to new
01:08medicines.
01:08The European Commission is assessing the
Comments